Susan E Connolly, MD
Ophthalmology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Connolly’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G69790 · Current
Licensed to practise in California · since 1990 · expires 2028-07-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$131,340
Medicare paid this office $131,340 for 658 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 548 | $73,270 | $106 |
| Imaging of optic nerve | 267 | $10,718 | $32 |
| Return visit (30+ min) | 63 | $9,742 | $116 |
| New patient visit (45+ min) | 75 | $9,626 | $128 |
| Imaging of retina | 194 | $8,340 | $36 |
See all 10 services
| Established patient complete exam of visual system | 548 | $73,270 | $106 |
| Imaging of optic nerve | 267 | $10,718 | $32 |
| Return visit (30+ min) | 63 | $9,742 | $116 |
| New patient visit (45+ min) | 75 | $9,626 | $128 |
| Imaging of retina | 194 | $8,340 | $36 |
| Exam of visual field with extended testing | 114 | $7,447 | $57 |
| Short return visit (20+ min) | 62 | $5,316 | $65 |
| Exam of visual field with limited testing | 85 | $2,860 | $32 |
| Photography of the retina | 34 | $1,203 | $34 |
| Ultrasound scan of cornea to determine thickness | 47 | $481 | $10 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
658 Original Medicare patients in 2024. Average age 77 · Women 62% · Also on Medicaid 6% · Health risk score 0.80. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 61% · Diabetes 25% · Coronary heart disease 21% · Chronic kidney disease 17% · Cancer 17% · Atrial fibrillation 13% · Depression 10% · Heart failure 9% · Stroke 5% · COPD 4% · Dementia 3%.
The office billed $619,498, Medicare allowed $194,805 and paid $131,340; for 1,836 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 658 | 1,836 | 77 | 0.80 | $619,498 | $131,340 |
| 2023 | 664 | 1,684 | 77 | 0.87 | $547,872 | $123,535 |
| 2022 | 692 | 1,730 | 77 | 0.81 | $540,658 | $129,383 |
| 2021 | 708 | 1,593 | 77 | 0.85 | $488,452 | $130,299 |
| 2020 | 219 | 351 | 77 | 0.80 | $111,888 | $17,550 |
| 2019 | 975 | 2,013 | 76 | 0.94 | $657,688 | $159,563 |
| 2018 | 1,056 | 2,096 | 76 | 0.88 | $684,991 | $165,902 |
| 2017 | 1,108 | 2,154 | 75 | 0.90 | $693,533 | $167,888 |
| 2016 | 1,083 | 2,038 | 75 | 0.93 | $663,945 | $167,171 |
| 2015 | 1,016 | 1,941 | 75 | 0.88 | $648,184 | $165,188 |
| 2014 | 1,168 | 2,179 | 75 | 0.84 | $729,261 | $177,073 |
| 2013 | 927 | 1,615 | 74 | 0.90 | $556,144 | $137,850 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Established patient complete exam of visual system | 515 | $69,052 | $110 |
| New patient visit (45+ min) | 111 | $13,527 | $122 |
| Imaging of optic nerve | 251 | $10,633 | $34 |
| Short return visit (20+ min) | 94 | $9,077 | $73 |
| Imaging of retina | 156 | $6,891 | $36 |
| Exam of visual field with extended testing | 99 | $6,330 | $58 |
| Exam of visual field with limited testing | 63 | $2,101 | $33 |
| Return visit (30+ min) | 12 | $1,627 | $125 |
| New patient visit (30+ min) | 12 | $1,098 | $92 |
| Photography of the retina | 28 | $1,042 | $35 |
| Ultrasound scan of cornea to determine thickness | 63 | $665 | $10 |
2022: 11 services
| Established patient complete exam of visual system | 502 | $67,223 | $111 |
| New patient visit (45+ min) | 135 | $15,878 | $118 |
| Short return visit (20+ min) | 128 | $15,087 | $76 |
| Imaging of optic nerve | 210 | $9,111 | $33 |
| Imaging of retina | 157 | $7,001 | $38 |
| Exam of visual field with extended testing | 92 | $6,503 | $60 |
| Exam of visual field with limited testing | 69 | $2,233 | $32 |
| New patient visit (30+ min) | 14 | $1,106 | $79 |
| Photography of the retina | 24 | $946 | $36 |
| Ultrasound scan of cornea to determine thickness | 62 | $680 | $10 |
| Extended exam of the back part of the eye with retinal drawing | 18 | $358 | $20 |
2021: 12 services
| Established patient complete exam of visual system | 521 | $67,670 | $118 |
| Short return visit (20+ min) | 129 | $16,319 | $87 |
| New patient visit (45+ min) | 107 | $15,345 | $143 |
| Imaging of optic nerve | 197 | $7,777 | $36 |
| Exam of visual field with extended testing | 109 | $7,336 | $64 |
| Imaging of retina | 141 | $6,547 | $41 |
| New patient visit (30+ min) | 12 | $1,323 | $110 |
| Exam of visual field with limited testing | 36 | $1,269 | $35 |
| Ultrasound scan of cornea to determine thickness | 96 | $1,018 | $10 |
| Photography of the retina | 18 | $736 | $39 |
| Exam of visual field with intermediate testing | 14 | $668 | $48 |
| Exam of the internal drainage system of eye | 11 | $312 | $28 |
2020: 6 services
| Established patient complete exam of visual system | 154 | $9,416 | $61 |
| Short return visit (20+ min) | 43 | $1,815 | $34 |
| New patient visit (45+ min) | 20 | $1,615 | $81 |
| Imaging of retina | 43 | $1,425 | $33 |
| Exam of visual field with extended testing | 24 | $1,224 | $51 |
| Imaging of optic nerve | 36 | $882 | $24 |
2019: 12 services
| Established patient complete exam of visual system | 698 | $89,985 | $106 |
| New patient visit (45+ min) | 161 | $19,034 | $118 |
| Short return visit (20+ min) | 163 | $16,662 | $64 |
| Imaging of retina | 177 | $9,033 | $39 |
| Imaging of optic nerve | 200 | $8,463 | $34 |
| Exam of visual field with extended testing | 92 | $6,147 | $60 |
| New patient visit (30+ min) | 31 | $2,828 | $91 |
| Return visit (30+ min) | 15 | $1,211 | $81 |
| Established patient problem focused exam of visual system | 12 | $963 | $74 |
| Examination of eye by ophthalmoscope with retinal drawing | 31 | $799 | $26 |
| Photography of the retina | 14 | $707 | $51 |
| Ultrasound scan of cornea to determine thickness | 23 | $253 | $11 |
2018: 12 services
| Established patient complete exam of visual system | 778 | $94,210 | $102 |
| New patient visit (45+ min) | 186 | $21,592 | $116 |
| Short return visit (20+ min) | 166 | $15,172 | $62 |
| Imaging of retina | 176 | $8,776 | $39 |
| Imaging of optic nerve | 179 | $7,522 | $35 |
| Exam of visual field with extended testing | 107 | $7,362 | $59 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $4,222 | $325 |
| Return visit (30+ min) | 20 | $1,975 | $99 |
| New patient visit (30+ min) | 23 | $1,728 | $75 |
| Examination of eye by ophthalmoscope with retinal drawing | 33 | $866 | $25 |
| Ultrasound scan of cornea to determine thickness | 37 | $519 | $14 |
| Removal of eyelashes using forceps | 11 | $513 | $37 |
2017: 11 services
| Established patient complete exam of visual system | 821 | $95,176 | $98 |
| New patient visit (45+ min) | 193 | $24,883 | $129 |
| Short return visit (20+ min) | 189 | $16,774 | $60 |
| Imaging of retina | 194 | $8,867 | $37 |
| Exam of visual field with extended testing | 111 | $7,716 | $58 |
| Imaging of optic nerve | 155 | $6,080 | $33 |
| New patient visit (30+ min) | 30 | $2,273 | $76 |
| Return visit (30+ min) | 11 | $1,035 | $94 |
| Examination of eye by ophthalmoscope with retinal drawing | 31 | $736 | $22 |
| Ultrasound scan of cornea to determine thickness | 34 | $478 | $14 |
| Exam of the internal drainage system of eye | 12 | $280 | $23 |
2016: 11 services
| Established patient complete exam of visual system | 792 | $96,465 | $100 |
| Short return visit (20+ min) | 221 | $22,327 | $61 |
| New patient visit (45+ min) | 156 | $19,746 | $127 |
| Exam of visual field with extended testing | 104 | $6,912 | $58 |
| Imaging of optic nerve | 136 | $6,505 | $41 |
| Imaging of retina | 75 | $3,552 | $42 |
| New patient visit (30+ min) | 43 | $3,485 | $81 |
| Removal of eyelashes using forceps | 19 | $1,073 | $47 |
| Examination of eye by ophthalmoscope with retinal drawing | 38 | $937 | $24 |
| Exam of the internal drainage system of eye | 13 | $320 | $25 |
| Ultrasound scan of cornea to determine thickness | 18 | $245 | $14 |
2015: 12 services
| Established patient complete exam of visual system | 776 | $98,976 | $108 |
| Short return visit (20+ min) | 207 | $19,732 | $62 |
| New patient visit (45+ min) | 136 | $18,828 | $138 |
| Exam of visual field with extended testing | 119 | $7,432 | $56 |
| Imaging of optic nerve | 129 | $6,807 | $44 |
| Imaging of retina | 118 | $6,095 | $46 |
| New patient visit (30+ min) | 22 | $1,993 | $91 |
| Removal of eyelashes using forceps | 13 | $864 | $45 |
| Examination of eye by ophthalmoscope with retinal drawing | 16 | $459 | $27 |
| Photography of content of eyes | 18 | $398 | $22 |
| Ultrasound scan of cornea to determine thickness | 25 | $344 | $14 |
| Exam of the internal drainage system of eye | 11 | $293 | $27 |
2014: 13 services
| Established patient complete exam of visual system | 820 | $96,641 | $101 |
| Short return visit (20+ min) | 214 | $23,561 | $59 |
| New patient visit (45+ min) | 150 | $20,475 | $136 |
| New patient complete exam of visual system | 88 | $8,058 | $92 |
| Exam of visual field with extended testing | 87 | $5,874 | $57 |
| Imaging of optic nerve | 122 | $5,657 | $42 |
| Imaging of retina | 91 | $4,831 | $44 |
| New patient visit (30+ min) | 36 | $2,933 | $81 |
| Removal of eyelashes using forceps | 18 | $1,265 | $44 |
| Exam of visual field with limited testing | 34 | $1,128 | $33 |
| Examination of eye by ophthalmoscope with retinal drawing | 36 | $932 | $26 |
| Ultrasound scan of cornea to determine thickness | 37 | $515 | $14 |
| Exam of the internal drainage system of eye | 14 | $364 | $26 |
2013: 10 services
| Established patient complete exam of visual system | 731 | $85,121 | $103 |
| New patient complete exam of visual system | 137 | $17,285 | $126 |
| Short return visit (20+ min) | 152 | $15,105 | $64 |
| Exam of visual field with extended testing | 77 | $5,494 | $62 |
| Imaging of optic nerve | 97 | $4,265 | $42 |
| Imaging of retina | 74 | $3,985 | $44 |
| New patient visit (30+ min) | 20 | $1,714 | $86 |
| Examination of eye by ophthalmoscope with retinal drawing | 30 | $771 | $26 |
| Removal of eyelashes using forceps | 12 | $718 | $48 |
| Ultrasound scan of cornea to determine thickness | 31 | $418 | $13 |
Medicaid work
$251 in 2024
Medicaid paid $251 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $251 |
| 2024 | 12 | 1 | 12 | $251 |
| 2020 | 13 | 1 | 12 | $453 |
| 2018 | 14 | 1 | 14 | $834 |
See the largest Medicaid services in earlier years
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $453 |
2018
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $834 |
Drugs they prescribed that Part D paid
$121,049
Pharmacies billed $121,049 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 685) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
354 generic and 331 brand-name prescriptions · $121,049 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xiidra | 38 | $38,787 | $1,021 |
| Restasis | 38 | $28,728 | $756 |
| Cyclosporine | 26 | $10,483 | $403 |
| Simbrinza | 33 | $7,903 | $239 |
| Travoprost | 32 | $6,856 | $214 |
See all 16 drugs
| Xiidra | 38 | $38,787 | $1,021 |
| Restasis | 38 | $28,728 | $756 |
| Cyclosporine | 26 | $10,483 | $403 |
| Simbrinza | 33 | $7,903 | $239 |
| Travoprost | 32 | $6,856 | $214 |
| Lumigan | 17 | $5,513 | $324 |
| Combigan | 12 | $2,333 | $194 |
| Latanoprost | 159 | $1,345 | $8 |
| Erythromycin | 105 | $1,150 | $11 |
| Brimonidine | 37 | $1,042 | $28 |
| Neomycin-Polymyxin-Dexameth | 43 | $509 | $12 |
| Tobramycin-Dexamethasone | 18 | $502 | $28 |
| Dorzolamide-Timolol | 22 | $467 | $21 |
| Moxifloxacin | 23 | $413 | $18 |
| Dorzolamide | 30 | $372 | $12 |
| Timolol Maleate | 12 | $140 | $12 |
Year by year
| 2024 | 685 | 220 | 0% (0) | 48% | $121,049 |
| 2023 | 589 | 215 | 0% (0) | 43% | $126,056 |
| 2022 | 638 | 221 | 0% (0) | 41% | $130,851 |
| 2021 | 507 | 205 | 0% (0) | 47% | $121,721 |
| 2020 | 529 | 168 | 0% (0) | 54% | $151,956 |
| 2019 | 924 | 322 | 0% (0) | 48% | $181,383 |
| 2018 | 976 | 305 | 0% (0) | 50% | $180,636 |
| 2017 | 942 | 315 | 0% (0) | 54% | $142,333 |
| 2016 | 1,001 | 335 | 0% (0) | 52% | $119,761 |
| 2015 | 963 | 286 | None | 53% | $123,319 |
| 2014 | 922 | 304 | None | 60% | $109,170 |
| 2013 | 672 | 229 | None | 64% | $77,687 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Xiidra | 36 | $39,370 | $1,094 |
| Restasis | 31 | $34,797 | $1,122 |
| Travoprost | 37 | $10,143 | $274 |
| Cequa | 13 | $7,020 | $540 |
| Simbrinza | 21 | $4,434 | $211 |
| Latanoprost | 119 | $3,518 | $30 |
| Loteprednol Etabonate | 11 | $1,880 | $171 |
| Brimonidine | 38 | $1,595 | $42 |
| Dorzolamide | 40 | $1,522 | $38 |
| Erythromycin | 77 | $867 | $11 |
| Tobramycin-Dexamethasone | 13 | $806 | $62 |
| Neomycin-Polymyxin-Dexameth | 48 | $676 | $14 |
| Dorzolamide-Timolol | 17 | $528 | $31 |
| Moxifloxacin | 18 | $468 | $26 |
| Timolol Maleate | 19 | $191 | $10 |
2022: 15 drugs
| Xiidra | 37 | $40,480 | $1,094 |
| Restasis | 32 | $35,360 | $1,105 |
| Travoprost | 36 | $8,318 | $231 |
| Cequa | 15 | $8,062 | $537 |
| Combigan | 13 | $3,256 | $250 |
| Latanoprost | 98 | $3,242 | $33 |
| Brimonidine | 55 | $3,031 | $55 |
| Simbrinza | 12 | $2,454 | $205 |
| Dorzolamide | 36 | $1,490 | $41 |
| Erythromycin | 101 | $1,085 | $11 |
| Tobramycin-Dexamethasone | 13 | $1,032 | $79 |
| Moxifloxacin | 26 | $847 | $33 |
| Neomycin-Polymyxin-Dexameth | 58 | $822 | $14 |
| Dorzolamide-Timolol | 13 | $397 | $31 |
| Timolol Maleate | 14 | $237 | $17 |
2021: 11 drugs
| Xiidra | 36 | $40,299 | $1,119 |
| Restasis | 32 | $32,576 | $1,018 |
| Brimonidine | 46 | $4,707 | $102 |
| Travoprost | 11 | $4,424 | $402 |
| Travatan Z | 13 | $2,834 | $218 |
| Latanoprost | 72 | $2,748 | $38 |
| Olopatadine | 19 | $1,248 | $66 |
| Dorzolamide | 22 | $1,074 | $49 |
| Erythromycin | 84 | $1,000 | $12 |
| Neomycin-Polymyxin-Dexameth | 57 | $926 | $16 |
| Moxifloxacin | 12 | $381 | $32 |
2020: 16 drugs
| Restasis | 35 | $43,797 | $1,251 |
| Xiidra | 31 | $34,687 | $1,119 |
| Travoprost | 26 | $8,520 | $328 |
| Lumigan | 11 | $7,780 | $707 |
| Pazeo | 33 | $6,940 | $210 |
| Combigan | 14 | $6,705 | $479 |
| Travatan Z | 19 | $5,796 | $305 |
| Alphagan P | 12 | $5,274 | $439 |
| Brimonidine | 37 | $5,174 | $140 |
| Azopt | 11 | $3,791 | $345 |
| Latanoprost | 105 | $3,745 | $36 |
| Olopatadine | 46 | $3,452 | $75 |
| Dorzolamide | 25 | $1,653 | $66 |
| Erythromycin | 37 | $448 | $12 |
| Neomycin-Polymyxin-Dexameth | 20 | $294 | $15 |
| Timolol Maleate | 12 | $199 | $17 |
2019: 20 drugs
| Restasis | 54 | $58,438 | $1,082 |
| Xiidra | 24 | $29,651 | $1,235 |
| Travatan Z | 48 | $17,732 | $369 |
| Combigan | 23 | $9,619 | $418 |
| Pazeo | 40 | $8,294 | $207 |
| Brimonidine | 59 | $7,040 | $119 |
| Azopt | 18 | $6,458 | $359 |
| Latanoprost | 159 | $5,131 | $32 |
| Alphagan P | 15 | $4,826 | $322 |
| Olopatadine | 49 | $3,838 | $78 |
| Simbrinza | 14 | $2,425 | $173 |
| Dorzolamide | 33 | $1,919 | $58 |
| Neomycin-Polymyxin-Dexameth | 109 | $1,613 | $15 |
| Erythromycin | 133 | $1,581 | $12 |
| Tobramycin-Dexamethasone | 11 | $891 | $81 |
| Dorzolamide-Timolol | 11 | $523 | $48 |
| Moxifloxacin | 11 | $401 | $36 |
| Timolol Maleate | 18 | $317 | $18 |
| Azithromycin | 14 | $151 | $11 |
| Ciprofloxacin | 15 | $146 | $10 |
2018: 20 drugs
| Xiidra | 53 | $40,548 | $765 |
| Restasis | 36 | $39,991 | $1,111 |
| Travatan Z | 50 | $18,136 | $363 |
| Restasis Multidose | 11 | $12,735 | $1,158 |
| Pazeo | 36 | $10,754 | $299 |
| Brimonidine | 65 | $9,624 | $148 |
| Combigan | 20 | $7,346 | $367 |
| Lumigan | 16 | $7,112 | $444 |
| Alphagan P | 23 | $6,551 | $285 |
| Latanoprost | 154 | $4,301 | $28 |
| Olopatadine | 40 | $4,257 | $106 |
| Xalatan | 12 | $2,478 | $206 |
| Neomycin-Polymyxin-Dexameth | 160 | $2,218 | $14 |
| Simbrinza | 12 | $1,945 | $162 |
| Tobramycin-Dexamethasone | 14 | $1,079 | $77 |
| Erythromycin | 108 | $1,065 | $10 |
| Dorzolamide | 39 | $994 | $25 |
| Timolol Maleate | 19 | $442 | $23 |
| Moxifloxacin | 11 | $366 | $33 |
| Ciprofloxacin | 18 | $141 | $8 |
2017: 21 drugs
| Restasis | 28 | $29,883 | $1,067 |
| Travatan Z | 70 | $21,080 | $301 |
| Xiidra | 33 | $18,406 | $558 |
| Pazeo | 49 | $10,613 | $217 |
| Brimonidine | 62 | $8,060 | $130 |
| Combigan | 25 | $7,963 | $319 |
| Lumigan | 17 | $5,483 | $323 |
| Simbrinza | 27 | $3,791 | $140 |
| Alphagan P | 13 | $3,723 | $286 |
| Pataday | 18 | $3,575 | $199 |
| Latanoprost | 120 | $2,897 | $24 |
| Betimol | 16 | $2,507 | $157 |
| Xalatan | 12 | $2,235 | $186 |
| Neomycin-Polymyxin-Dexameth | 150 | $2,126 | $14 |
| Tobramycin-Dexamethasone | 19 | $1,433 | $75 |
| Olopatadine | 14 | $1,342 | $96 |
| Dorzolamide | 33 | $889 | $27 |
| Erythromycin | 83 | $806 | $10 |
| Dorzolamide-Timolol | 21 | $486 | $23 |
| Timolol Maleate | 16 | $287 | $18 |
| Ciprofloxacin | 25 | $219 | $9 |
2016: 25 drugs
| Restasis | 39 | $24,578 | $630 |
| Travatan Z | 63 | $16,026 | $254 |
| Brimonidine | 81 | $12,130 | $150 |
| Combigan | 26 | $7,330 | $282 |
| Lumigan | 18 | $5,440 | $302 |
| Pazeo | 21 | $4,434 | $211 |
| Alphagan P | 20 | $4,284 | $214 |
| Pataday | 20 | $3,914 | $196 |
| Lotemax | 17 | $3,640 | $214 |
| Tobramycin-Dexamethasone | 38 | $3,518 | $93 |
| Tobradex | 17 | $3,342 | $197 |
| Azopt | 11 | $2,903 | $264 |
| Neomycin-Polymyxin-Dexameth | 139 | $2,492 | $18 |
| Simbrinza | 17 | $2,277 | $134 |
| Latanoprost | 119 | $2,272 | $19 |
| Vigamox | 14 | $2,120 | $151 |
| Xalatan | 11 | $1,832 | $167 |
| Erythromycin | 115 | $1,357 | $12 |
| Fluorometholone | 12 | $797 | $66 |
| Dorzolamide | 17 | $629 | $37 |
| Dorzolamide-Timolol | 17 | $500 | $29 |
| Timolol Maleate | 22 | $442 | $20 |
| Ciprofloxacin | 25 | $241 | $10 |
| Azithromycin | 17 | $171 | $10 |
| Quetiapine | 12 | $131 | $11 |
2015: 20 drugs
| Restasis | 42 | $19,662 | $468 |
| Travatan Z | 66 | $13,088 | $198 |
| Truvada | 11 | $12,783 | $1,162 |
| Brimonidine | 66 | $10,738 | $163 |
| Lexiva | 13 | $6,525 | $502 |
| Pataday | 26 | $6,138 | $236 |
| Alphagan P | 28 | $5,831 | $208 |
| Azopt | 20 | $5,259 | $263 |
| Combigan | 21 | $4,390 | $209 |
| Tobradex | 21 | $4,034 | $192 |
| Tobramycin-Dexamethasone | 31 | $2,873 | $93 |
| Travoprost | 15 | $2,791 | $186 |
| Lastacaft | 16 | $2,555 | $160 |
| Latanoprost | 104 | $2,064 | $20 |
| Neomycin-Polymyxin-Dexameth | 126 | $2,063 | $16 |
| Lotemax | 11 | $1,888 | $172 |
| Erythromycin | 105 | $1,461 | $14 |
| Timolol Maleate | 25 | $1,341 | $54 |
| Dorzolamide | 25 | $644 | $26 |
| Ciprofloxacin | 34 | $323 | $9 |
2014: 19 drugs
| Travatan Z | 94 | $18,495 | $197 |
| Pataday | 63 | $11,422 | $181 |
| Restasis | 29 | $10,696 | $369 |
| Brimonidine | 54 | $9,861 | $183 |
| Tobramycin-Dexamethasone | 56 | $5,988 | $107 |
| Patanol | 27 | $5,690 | $211 |
| Tobradex | 31 | $5,513 | $178 |
| Alphagan P | 28 | $5,375 | $192 |
| Combigan | 18 | $4,552 | $253 |
| Lotemax | 18 | $4,199 | $233 |
| Lumigan | 15 | $3,458 | $231 |
| Azopt | 16 | $2,755 | $172 |
| Latanoprost | 78 | $1,554 | $20 |
| Erythromycin | 107 | $1,537 | $14 |
| Neomycin-Polymyxin-Dexameth | 77 | $1,427 | $19 |
| Timolol Maleate | 27 | $1,211 | $45 |
| Dorzolamide | 27 | $865 | $32 |
| Fluorometholone | 11 | $777 | $71 |
| Ciprofloxacin | 28 | $273 | $10 |
2013: 17 drugs
| Travatan Z | 78 | $14,342 | $184 |
| Pataday | 41 | $7,703 | $188 |
| Lotemax | 32 | $6,724 | $210 |
| Alphagan P | 32 | $6,402 | $200 |
| Brimonidine | 42 | $5,740 | $137 |
| Tobramycin-Dexamethasone | 47 | $5,699 | $121 |
| Tobradex | 32 | $5,279 | $165 |
| Lumigan | 18 | $4,155 | $231 |
| Restasis | 11 | $3,723 | $338 |
| Patanol | 20 | $3,474 | $174 |
| Latanoprost | 66 | $1,746 | $26 |
| Erythromycin | 65 | $1,031 | $16 |
| Neomycin-Polymyxin-Dexameth | 38 | $702 | $18 |
| Dorzolamide | 21 | $693 | $33 |
| Timolol Maleate | 22 | $430 | $20 |
| Ciprofloxacin | 17 | $253 | $15 |
| Azithromycin | 12 | $237 | $20 |
Money from drug and device companies
$58 in 2025
A payment is not proof that care is biased.
| Boston Scientific | Embold Fibered | $31 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $26 | 1 payment
|
See all 2 published payments
| Edwards Lifesciences | Meals · 2025-09-11 | Sapien 3 Ultra Resilia | $26 |
| Boston Scientific | Meals · 2025-01-23 | Embold Fibered | $31 |
Professional record
- NPI
- 1861501900
- Licence
- CA G69790California G69790: Current · expires 2028-07-31
- Trained
- Harvard Medical School, 1989
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-08-30
- NPI last updated
- 2020-03-06
- NPI record certified
- 2020-03-06
This is when the NPI record was last certified, not a medical board exam.